Pravastatin [orch, phsu]
pharmacoeconomic [qnco]
Review [inpr]
Primary [qlco]
Secondary Prevention [topp]
coronary heart disease [dsyn]
coronary heart disease [dsyn]
Major [qlco]
Death [orgf]
Illness [fndg]
Countries [geoa]
Pravastatin [orch, phsu]
Low density lipoprotein cholesterol level [lbpr]
Increase [ftcn]
High density lipoprotein cholesterol level [lbpr]
Cholesterol [bacs, strd]
Modification [ftcn]
Pravastatin [orch, phsu]
Middle Aged [aggp]
Men [popg]
coronary heart disease [dsyn]
i e [diap, inpr]
Primary Prevention [topp]
Show [inpr]
In [qnco]
West [spco]
Scotland [geoa]
coronary [bpoc]
Prevention Study [resa]
Incidence [qnco]
Fatal [qlco]
coronary [bpoc]
Events [evnt]
Several [qnco]
Large [qnco]
studies [lbpr]
Pravastatin [orch, phsu]
Reduced [qlco]
Incidence [qnco]
coronary heart disease [dsyn]
Events [evnt]
Patients [podg]
Prior [tmco]
coronary heart disease [dsyn]
Secondary Prevention [topp]
Large [qnco]
Long-term [tmco]
Study [mnob]
Relationship [qlco]
Cholesterol [bacs, strd]
Modification [ftcn]
coronary heart disease [dsyn]
Event [evnt]
Rate [acty]
Conduct [inbe]
Not [ftcn]
pharmacoeconomic [qnco]
Analysis [lbpr]
Of [spco]
West [spco]
Scotland [geoa]
coronary [bpoc]
Prevention Study [resa]
Data [idcn]
Indicated [fndg]
Primary Prevention [topp]
Pravastatin [orch, phsu]
Associated [qlco]
Cost [qnco]
pound [qnco]
per year [tmco]
Life [idcn]
Gain [qnco]
discount [inpr]
treatment [ftcn]
Men [popg]
High Risk [qlco]
coronary heart disease [dsyn]
Result [ftcn]
Lower [spco]
Cost [qnco]
Estimate [qnco]
pound [qnco]
Life [idcn]
Gain [qnco]
economic analysis [ocac]
Based [ftcn]
Secondary Prevention [topp]
Pravastatin [orch, phsu]
Large [qnco]
Plaque [dsyn]
Regression [patf]
studies [lbpr]
Suggest [idcn]
Reticular [spco]
Cost [qnco]
Drug Therapy [topp]
per year [tmco]
Life [idcn]
Gain [qnco]
Projected [inpr]
Risk [qlco]
Models [inpr]
Attempt [evnt]
To [qlco]
Calculate [acty]
Cost Effectiveness [qnco]
Primary [qlco]
Secondary Prevention [topp]
Pravastatin [orch, phsu]
Compared [acty]
Lipid [lipd]
MODIFY [ftcn]
interventions [hlca]
Comparison [acty]
Indicated [fndg]
Pravastatin [orch, phsu]
Economically [ocdi]
Superior [spco]
Life Style [socb]
Counseling [hlca]
Drug Therapy [topp]
Pravastatin [orch, phsu]
APPEAR [qlco]
To [qlco]
Cost Effectiveness [qnco]
Relative [famg]
Effectiveness [qlco]
Various [irda]
Drugs [phsu]
depend [medd]
Model [inpr]
considered [idcn]
Risk [qlco]
Projection [inpr]
Models, Economic [inpr, qnco]
methodology [inpr]
limitations [ftcn]
estimating [qnco]
Clinical [qlco]
Effectiveness [qlco]
Epidemiological [bmod]
Data [idcn]
Often [tmco]
Derived [qlco]
Framingham [inpr]
Heart study [diap]
Increased [qnco]
absolute risk [qnco]
coronary heart disease [dsyn]
Cost Effectiveness [qnco]
Lipid-lowering therapy [topp]
Cost [qnco]
per year [tmco]
Life [idcn]
Gain [qnco]
Pravastatin [orch, phsu]
Secondary Prevention [topp]
General [spco]
Lower [spco]
Primary Prevention [topp]
Reflecting [menp]
High Risk [qlco]
Absolute [qlco]
Second [qnco]
First [qnco]
coronary heart disease [dsyn]
Events [evnt]
Note [clna]
Individual [popg]
absolute risk [qnco]
Rate [acty]
overlap [topp]
Patients [podg]
Receive [qlco]
Primary [qlco]
Secondary Prevention [topp]
treatment [ftcn]
Select [acty]
Individual [popg]
Patients [podg]
High Risk [qlco]
Id [idcn]
Events [evnt]
Associated [qlco]
Lower [spco]
Cost [qnco]
per year [tmco]
Life [idcn]
Gain [qnco]
treatment [ftcn]
Conclusion [idcn]
Large [qnco]
Clinical Studies [resa]
Pravastatin [orch, phsu]
Reduced [qlco]
Risk [qlco]
Primary [qlco]
secondary [neop]
coronary heart disease [dsyn]
Events [evnt]
Benefits [qnco]
economic cost [qnco]
One [qnco]
Accepted [qlco]
Costs [qnco]
Medical [ftcn]
interventions [hlca]
treatment [ftcn]
Patients [podg]
Population [qnco]
High Risk [qlco]
coronary heart disease [dsyn]
Events [evnt]
Cost Effectiveness [qnco]
Pravastatin [orch, phsu]
therapy [ftcn]
